Buy high-quality intermediate from China manufacturer

The product is Pyridine, 2,6-dichloro-4-(1,1-dimethylethyl)-, a symmetric, sterically encumbered pyridine derivative in which the 4‑position is occupied by a bulky tert‑butyl group and both the 2‑ and 6‑positions are substituted with chlorine atoms. The two identical C–Cl bonds provide leverage for selective, sequential cross‑coupling or nucleophilic aromatic substitution, while the tert‑butyl group shields the 4‑position from undesired reactions and profoundly influences the conformation and lipophilicity of downstream derivatives. This combination of a highly activated pyridine core and a strategically placed blocking group makes the molecule a privileged starting material for the construction of unsymmetrically substituted pyridine libraries.

The product is 4-Bromo-3,5-dimethyl-1-(THP)-1H-pyrazole, a fully substituted pyrazole ring carrying two methyl groups at the 3‑ and 5‑positions, a bromine atom at the 4‑position, and a tetrahydropyran‑2‑yl (THP) protecting group on the sp²‑hybridized nitrogen. The methyl groups provide electron density and steric shielding to the pyrazole core, while the C4‑bromine serves as an excellent handle for palladium‑catalyzed cross‑coupling, lithiation‑halogen exchange, or direct nucleophilic aromatic substitution. The THP group prevents tautomerization of the pyrazole and protects the N–H from deprotonation during organometallic reactions, enabling selective functionalization at C4 without competing N‑alkylation or ring metallation.

The product is 3,5-Dimethyl-1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, a fully elaborated pyrazole‑4‑boronic ester bearing two electron‑donating methyl groups at the 3‑ and 5‑positions and a tetrahydropyran‑2‑yl (THP) protecting group on nitrogen. The pinacol boronate ester provides an sp²‑hybridized carbon–boron bond that is activated for palladium‑catalyzed Suzuki‑Miyaura cross‑coupling, enabling the direct installation of the 1‑THP‑3,5‑dimethylpyrazole‑4‑yl fragment onto aryl, heteroaryl, or alkenyl halides. The THP group safeguards the pyrazole N–H during the coupling step and can be cleaved under mild acidic conditions after coupling to liberate the free pyrazole, making this an exceptionally convenient, ready‑to‑couple building block for medicinal and process chemistry.

The product is 4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene, a trisubstituted benzene that combines three electronically and sterically distinct functional groups: a benzylic chloromethyl moiety for nucleophilic substitution, a cyclopentyl ring that introduces saturated bulk, and a trifluoromethyl group that drastically modulates lipophilicity and metabolic stability. The 1,2,4‑substitution pattern places the chloromethyl and trifluoromethyl groups on adjacent carbon atoms, creating a unique environment where the electron‑withdrawing CF₃ group influences the reactivity of the benzylic chloride. This compound serves as a powerful alkylating agent and a key intermediate for constructing complex molecules where a rigid, fluorine‑rich aromatic ring is desired.

The product is 2,6-difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, a difluorinated aniline carrying a pinacol boronate ester at the para position relative to the amino group. The two fluorine atoms at the 2‑ and 6‑positions modulate both the electronic character of the aromatic ring and the basicity of the adjacent aniline nitrogen, while the boron‑containing dioxaborolane unit furnishes a robust handle for palladium‑catalyzed cross‑coupling. This combination of a nucleophilic amine and an electrophilic boronate ester in the same molecule, together with the fluorine‑induced electronic tuning, makes it a uniquely versatile building block for constructing complex, polysubstituted arenes in drug discovery.

The product is 7-Chloro-1H-pyrazolo[4,3-d]pyrimidine, a fused bicyclic heteroaromatic ring system that merges a pyrazole and a pyrimidine with a chlorine atom at the 7‑position. The scaffold presents three sp²‑hybridized nitrogen atoms — two in the pyrimidine ring and one in the pyrazole — which can act as hydrogen‑bond acceptors, while the pyrazole N–H serves as a donor. The chlorine is activated for nucleophilic aromatic substitution (SₙAr) and palladium‑catalyzed cross‑couplings, making this compound a central intermediate for the synthesis of kinase inhibitors, particularly those that target the ATP‑binding site.